Cargando…
Sodium oligomannate therapeutically remodels gut microbiota and suppresses gut bacterial amino acids-shaped neuroinflammation to inhibit Alzheimer’s disease progression
Recently, increasing evidence has suggested the association between gut dysbiosis and Alzheimer’s disease (AD) progression, yet the role of gut microbiota in AD pathogenesis remains obscure. Herein, we provide a potential mechanistic link between gut microbiota dysbiosis and neuroinflammation in AD...
Autores principales: | Wang, Xinyi, Sun, Guangqiang, Feng, Teng, Zhang, Jing, Huang, Xun, Wang, Tao, Xie, Zuoquan, Chu, Xingkun, Yang, Jun, Wang, Huan, Chang, Shuaishuai, Gong, Yanxue, Ruan, Lingfei, Zhang, Guanqun, Yan, Siyuan, Lian, Wen, Du, Chen, Yang, Dabing, Zhang, Qingli, Lin, Feifei, Liu, Jia, Zhang, Haiyan, Ge, Changrong, Xiao, Shifu, Ding, Jian, Geng, Meiyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6796854/ https://www.ncbi.nlm.nih.gov/pubmed/31488882 http://dx.doi.org/10.1038/s41422-019-0216-x |
Ejemplares similares
-
Geng et al. reply
por: Wang, Xinyi, et al.
Publicado: (2020) -
A phase II randomized trial of sodium oligomannate in Alzheimer’s dementia
por: Wang, Tao, et al.
Publicado: (2020) -
Pharmacokinetics, distribution, and excretion of sodium oligomannate, a recently approved anti-Alzheimer's disease drug in China
por: Lu, Jiaojiao, et al.
Publicado: (2022) -
Sodium oligomannate combined with rivastigmine may improve cerebral blood flow and cognitive impairment following CAR-T cell therapy: A case report
por: Wang, Yan-Li, et al.
Publicado: (2022) -
Chronic Kidney Disease and Cognitive Impairment: The Kidney-Brain Axis
por: Xie, Zuoquan, et al.
Publicado: (2022)